NIPT TriSure Basic (trisomies 13, 18, 21, fetal sex determination) with maternal alpha-thalassemia screening

About

Method — Next-Generation Sequencing (NGS). NIPT TriSure Basic is a non-invasive prenatal screening test for fetal chromosomal abnormalities in early pregnancy. The test assesses the risk of the most common genetic abnormalities: trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and determines fetal sex. The panel also includes alpha-thalassemia screening for the mother. Features of NIPT TriSure Basic: Uses advanced Next-Generation Sequencing (NGS) technology Blood sample (10 ml) is collected by a qualified professional, with no risk to the pregnancy Can be performed from week 9 of pregnancy Includes free teleconsultation and additional diagnostic support in case of a high-risk result